Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant
about
Use of Carnosine for Oxidative Stress Reduction in Different PathologiesEvidence for beneficial effects of vitamin ELipid peroxidation and its toxicological implicationsNew parenteral lipid emulsions for clinical useChemistry and biology of vitamin EInduction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and eAn essential difference between the flavonoids monoHER and quercetin in their interplay with the endogenous antioxidant networkReconciling the chemistry and biology of reactive oxygen speciesEffect of dietary treatment with n-propyl gallate or vitamin E on the survival of mice exposed to phosgene.Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer.A role for reduced coenzyme Q in atherosclerosis?Oxidative injury and inflammatory periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen species.Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.Gamma-tocopherol--an underestimated vitamin?p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E.High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring.Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis?Biomarkers of Oxidative Stress Study IV: ozone exposure of rats and its effect on antioxidants in plasma and bronchoalveolar lavage fluidNOX1, 2, 4, 5: counting out oxidative stress.Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial.Biomarkers of oxidative stress study VI. Endogenous plasma antioxidants fail as useful biomarkers of endotoxin-induced oxidative stress.Oxidized low-density lipoprotein.Plasma vitamin E and coenzyme Q10 are not associated with a lower risk of acute myocardial infarction in Singapore Chinese adults.Glucocorticoids Suppress Mitochondrial Oxidant Production via Upregulation of Uncoupling Protein 2 in Hyperglycemic Endothelial CellsAre we over oxidized? Oxidative stress, cardiovascular disease, and the future of intervention studies with antioxidantsAntioxidants and atherosclerosis: emerging drug therapies.Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesisPathophysiology and Medical Treatment of Carotid Artery Stenosis.Alpha-tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipidsAntioxidants: the good, the bad and the uglyPotential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.Mechanisms of combined action of different chemopreventive dietary compounds: a review.Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathioneAntiatherogenic effects of vitamin E: the search for the Holy Grail.Nutrition and heart failure: impact of drug therapies and management strategies.Vitamin E does not slow the progression of hypercholesterolemic atherosclerosis.
P2860
Q26767420-311BD136-5437-432C-8AD8-996EE1137588Q26782132-69487B90-6F4E-4158-83A5-32D980D4792EQ27691302-80E6AD0B-0110-4A1B-9763-C928E46EB0E1Q28248812-780061BC-7D70-404D-A365-271FD5C30342Q28296736-4F325BB5-5495-4169-A2A6-39EA217C3BB8Q28395954-0E694DC0-AF17-4725-B128-889D9A67319DQ28476023-444FA878-14C5-4613-AC3D-56AABB3627A0Q29615709-C2FDF04E-4273-41D0-B2A1-EFA6998D304CQ31948108-714B56D1-1FDE-4F93-9ED0-A04AB7939892Q32079135-AEB99B1C-F110-4778-83F9-B0C5A36389F0Q33693133-674E2B8A-FC3B-4CB2-930F-57A202A853CAQ33817056-A20332EA-1CA4-4539-9968-42BEEDB78278Q34127841-0BC3B4CE-FF48-4B47-8176-FB57228EE8F7Q34131085-121505B1-AE02-47C6-8B7E-89E56A4C7E80Q34145731-E58548DE-0927-44EF-9470-1FD7519B24D2Q34333824-3351F8ED-3B07-450F-BFEA-7062CE03BA46Q34786224-7CD69BB2-FADB-4392-A651-46C8F57940C4Q34935156-277D6FDC-1129-4AB5-80CF-90433D88E87CQ35062312-57F37132-0DAC-4C99-9EFF-014D44451CDEQ35370716-934822C1-C899-47E6-9445-A89A6B55246EQ35375986-DCCCFFA0-0F79-4DF7-B212-ADAECD56B250Q35581462-2BE25AE7-1A72-4A79-9A90-91710671E717Q35674807-3E1827E0-371C-4528-94F8-4DD8C12430D5Q35743923-A3583897-AD5F-42C2-A8B7-7041FBF07417Q35860737-5E19BA07-0EF4-4029-8944-1DB692FA7F24Q35952302-BC3F6A8B-F911-47C1-B063-CAA32BF21960Q36003163-518494AF-BC5C-4EE9-908D-F5EFECBAE4BFQ36012825-E89BEBBE-FB0B-40DB-94AD-DD918206D6D3Q36026006-F8C009E8-B954-409F-A28F-15085B8E7FCDQ36052417-15A227AE-218A-4FBC-B435-611EFB11274CQ36065338-C0B1AE55-AF86-42EB-B3C0-BE8186B1B8B1Q36297106-50B517FC-F607-4926-97A6-973A9556DB25Q36405142-6EDCE026-837C-40BB-980F-1C4BAF62215BQ36484657-61F97541-746F-4863-982C-3DCDBB53A940Q36625116-1AE4EDD9-CF1D-4692-A752-546D9AA5B087Q37155539-BCFD1B12-88C8-482E-90C1-4F2C4455E9A1Q37199766-E9734CCD-733B-49C4-BA0D-D37F49327F2AQ37354661-2E399AE1-0E8A-4779-AB73-A7E20CAD68F6Q37401599-08DDDB69-CC3A-4406-B192-3E69C4BFE734Q37429127-922C0041-63CB-46E6-B0E4-73A62445838B
P2860
Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@ast
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@en
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@en-gb
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@nl
type
label
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@ast
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@en
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@en-gb
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@nl
prefLabel
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@ast
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@en
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@en-gb
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@nl
P2093
P2860
P3181
P356
P1433
P1476
Vitamin E in human low-density ...... ioxidant becomes a pro-oxidant
@en
P2093
P2860
P3181
P356
10.1042/BJ2880341
P407
P478
288 ( Pt 2)
P577
1992-12-01T00:00:00Z